Showing results (311-320 of 465) with videos related to

Sort By:
Pageof 47
BMC Pulmonary Medicine|February 2, 2023
Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILEGizal Nakshbandi, Catharina C Moor, Katerina Antoniou, et al.
Addiction Science & Clinical Practice|July 9, 2025
Integrating an exercise program into opioid agonist therapy: a pilot study on feasibility, fitness improvements, and participation challengesEinar Furulund, Siv-Elin Leirvåg Carlsen, Silvia Eiken Alpers, et al.
The Journal of Rheumatology|January 17, 2017
Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient CohortAnna-Maria Hoffmann-Vold, Øyvind Midtvedt, Anders H Tennøe, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 21, 2022
The G213D variant in Nav1.5 alters sodium current and causes an arrhythmogenic phenotype resulting in a multifocal ectopic Purkinje-related premature contraction phenotype in human-induced pluripotent stem cell-derived cardiomyocytesKirstine Calloe, Michelle Geryk, Kristine Freude, et al.
Annals of the Rheumatic Diseases|April 30, 2026
Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trialAnna-Maria Hoffmann-Vold, Shervin Assassi, Vincent Cottin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 25, 2018
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic SclerosisAnna-Maria Hoffmann-Vold, Roger Hesselstrand, Håvard Fretheim, et al.
ACR Open Rheumatology|November 29, 2019
Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic ImplicationsAnders H Tennøe, Klaus Murbræch, Johanna C Andreassen, et al.
Pageof 47